Medivir AB Appoints Luxembourg Pharmaceuticals Ltd. as Distributor for Xerclear(TM) in Israel and the Palestinean Authority
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIRB), the research-based speciality pharmaceutical company focused on infectious diseases, is today pleased to announce the appointment of Luxembourg Pharmaceuticals Ltd, as the exclusive distributor for Xerclear™, Medivir’s marketed and innovative treatment for recurrent cold sores, in Israel and the Palestinian Authority.